300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Theatre
Transportation
Enterprise
Community
Media (Entertainment)
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
KCK, VC Fund

KCK

VC Fund

New York, United States

KCK is a family investment fund that invests in a diverse set of industries, including medical technologies. KCK interests in Life Sciences - Biopharm/ Biotech & MedTech, Energy, Science-rich companies and Industrial Technologies. KCK invest at all stages of a startup's from early stage to growth rounds and also invest in publiccompanies. KCK is the private equity arm of a family office which seeks to partner with experienced management teams, focused on niche markets, deploying long-term flexible capital to generate high risk-adjusted returns.

Total investments:
38
Last investment:
Lead investor:
42%

Last updated:

Industries KCK invests in

Health CareMedical DeviceBiotechnologyMedicalMobile

Stages KCK invests in

Series CFunding RoundSeries DSeries BPrivate Equity

Countries KCK invests in

United StatesIrelandIndiaIsraelGermany

Round sizes

Series C $44M–$100MSeries D $31M–$100M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

3 more contacts available

Round size

Series C
$44M–$100M
Series D
$31M–$100M

Investment Focus

Industry

  • Health Care 9 (24%)
  • Medical Device 7 (18%)
  • Biotechnology 6 (16%)
  • Medical 4 (11%)
  • Mobile 3 (8%)
See all 47 industries →

Stage

  • Series C 6 (16%)
  • Funding Round 6 (16%)
  • Series D 5 (13%)
  • Series B 4 (11%)
  • Private Equity 3 (8%)
See all 10 stages →

Country

  • United States 14 (37%)
  • Ireland 2 (5%)
  • India 1 (3%)
  • Israel 1 (3%)
  • Germany 1 (3%)
See all 6 countries →

Team

NameTitleInvestmentsLinksEmail
Greg Garfield
Greg Garfield Senior Managing Director
Senior Managing Director Total investments: 7
Find email
Nael Kassar Founder
Founder Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Chain Reaction Chain Reaction
Chain Reaction is engineering the future of disruptive blockchain and privacy technologies. They accelerate compute performance, enabling companies to adopt and scale solutions to the world’s most complex problems.EL3CTRUM is their Blockchain product line, starting with the most efficient hashing ASIC on the market, optimized forhigh-performance, high efficiency, and low-power, and is the heart of their hashboards and systems. EL3CTRUM delivers optimal payback time.3PU™ is their Privacy product, dramatically accelerating real-time operations of Privacy Enhancing Technologies on encrypted data, transforming the cloud into a trusted environment, and enabling new verticals to adopt the cloud at scale, including financial institutions, healthcare & big pharma, defense & government, oil & gas, and more. Purpose-built and custom-designed, their solutions power the next generation of secure, scalable, green computing to help protect people, privacy, and the planet. $70M / Series C / Feb 23, 2023
Chain Reaction Chain Reaction
Chain Reaction is engineering the future of disruptive blockchain and privacy technologies. They accelerate compute performance, enabling companies to adopt and scale solutions to the world’s most complex problems.EL3CTRUM is their Blockchain product line, starting with the most efficient hashing ASIC on the market, optimized forhigh-performance, high efficiency, and low-power, and is the heart of their hashboards and systems. EL3CTRUM delivers optimal payback time.3PU™ is their Privacy product, dramatically accelerating real-time operations of Privacy Enhancing Technologies on encrypted data, transforming the cloud into a trusted environment, and enabling new verticals to adopt the cloud at scale, including financial institutions, healthcare & big pharma, defense & government, oil & gas, and more. Purpose-built and custom-designed, their solutions power the next generation of secure, scalable, green computing to help protect people, privacy, and the planet. $70M / Series C / Feb 23, 2023
Dubizzle Group Dubizzle Group
The Emerging Markets Property Group (EMPG) owns and operates bespoke property verticals in emerging markets, primarily in the Middle East and South Asia. The group’s flagship ventures are Bayut.com in the UAE, Zameen.com in Pakistan and Bproperty.com in Bangladesh.They disrupt traditional processes in emerging markets by introducing solutionsthat make property searching faster, easier, and simpler. Their competitive advantage comes from the tremendous value they add to the businesses that work with their portals, and the significant ease we provide to end users.At EMPG, they are not interested in maintaining the status quo. Their property verticals in emerging markets completely redefine the way the property business is done there, and they are especially tuned into the unique requirements of these markets because they are borne of one. $200M / Private Equity / Oct 27, 2022
Wunder Mobility Wunder Mobility
Wunder Mobility is a software and hardware provider for vehicle sharing. Its highly customizable and deeply integrated software solution is complemented by a sharing-ready vehicle program built in partnership with manufacturers. $11.9M / Series B / Oct 05, 2022
Aerin Medical Aerin Medical
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. $60M / Private Equity / Jun 16, 2022
Chain Reaction Chain Reaction
Chain Reaction is engineering the future of disruptive blockchain and privacy technologies. They accelerate compute performance, enabling companies to adopt and scale solutions to the world’s most complex problems.EL3CTRUM is their Blockchain product line, starting with the most efficient hashing ASIC on the market, optimized forhigh-performance, high efficiency, and low-power, and is the heart of their hashboards and systems. EL3CTRUM delivers optimal payback time.3PU™ is their Privacy product, dramatically accelerating real-time operations of Privacy Enhancing Technologies on encrypted data, transforming the cloud into a trusted environment, and enabling new verticals to adopt the cloud at scale, including financial institutions, healthcare & big pharma, defense & government, oil & gas, and more. Purpose-built and custom-designed, their solutions power the next generation of secure, scalable, green computing to help protect people, privacy, and the planet. $70M / Series C / May 01, 2022
RefleXion Medical RefleXion Medical
RefleXion is developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT),stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency. $80M / Mar 10, 2022
RefleXion Medical RefleXion Medical
RefleXion is developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT),stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency. $80M / Series E / Mar 10, 2022
Mainspring Energy Mainspring Energy
Mainspring Energy is engineering advanced technology to revolutionize the way electricity is generated and delivered $95M / Series D / May 04, 2021
Crusoe Crusoe
Crusoe is on a mission to help the oil industry reduce routine flaring of natural gas. They are passionate about creating solutions that benefit the environment, local communities, and energy producers.Crusoe Energy Systems provides oil and gas companies with a fast, low cost and simple solution to natural gas flaring. As the energy industrystruggles with pipeline constraints and increasing regulations around flaring and combusting, Crusoe is here to help. Their service lets operators preserve or regain regulatory compliance, maintain existing production and facilitate future development. $128M / Series B / Apr 26, 2021
See all 38 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Theatre
Transportation
Enterprise
Community
Media (Entertainment)
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does KCK invest in?

KCK invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Series C and Funding Round stage. Most of the 38 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is KCK's check size?

KCK typically joins rounds of $44M–$100M at Series C and $31M–$100M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds KCK participates in.

How do I contact KCK?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at KCK?

The team at KCK includes Greg Garfield (Senior Managing Director) and Nael Kassar (Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
KCK KCK Find emails